- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01176838
A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients
November 3, 2017 updated by: Wake Forest University
A Prospective Study on Newly Diagnosed Breast Cancer Patients: A 5 Year Follow Up on Quality of Life
The purpose of this study is to provide the physicians with quality long term follow up data on subjects from the Breast Cancer Clinic and the Plastic Surgery Clinic who have been newly diagnosed with breast cancer and will receive treatment for the cancer at this facility.
Over the last two decades many studies have been done concerning the quality of life after a mastectomy and/or reconstruction process.
The majority of these studies only run for one year post reconstruction, some however, do include a two year follow up.
The investigators are proposing a 5 year long term follow up study on subjects who will be diagnosed and treated here at the Breast Cancer Clinic and the Plastic Surgery Clinic.
The investigators first questionnaire will be given prior to any treatment for breast cancer, giving us a baseline for the subject's current quality of life.
At each successive year, the subject will be given another questionnaire with regards to their progression through the reconstructive process.
At the end of 5 years, the subject will complete a final questionnaire.
These questionnaires will deal with many areas of daily life functions; activities of daily living, anxiety, depression, social interactions, personal and sexual relationships.
Study Overview
Status
Terminated
Conditions
Detailed Description
Upon informed consent of subject, a baseline questionnaire will be completed by the subject.
At years 1, 2, 3, and 4 follow up questionnaires will be sent for completion to the subject.
At year 5 a final questionnaire will be sent to the subject for completion.After all subjects have completed the study, data will be sent to the Department of Biostatics for analysis.
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Department of Plastic & Reconstructive Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
The study population will consist of females ages 18 and over that have been newly diagnosed with breast cancer.
Description
Inclusion Criteria:
Any female age 18 or over that has been diagnosed with breast cancer and has been treated and followed in the Breast Cancer Clinic and the Plastic Surgery Clinic is eligible for study participation.
Exclusion Criteria:
Any person not meeting these requirements will not be eligible for study participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lisa R David, MD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2008
Primary Completion (Actual)
August 1, 2015
Study Completion (Actual)
August 1, 2015
Study Registration Dates
First Submitted
August 5, 2010
First Submitted That Met QC Criteria
August 5, 2010
First Posted (Estimate)
August 6, 2010
Study Record Updates
Last Update Posted (Actual)
November 7, 2017
Last Update Submitted That Met QC Criteria
November 3, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00007317
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Newly Diagnosed Breast Cancer
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer CenterActive, not recruiting
-
Weill Medical College of Cornell UniversityTerminatedNewly Diagnosed Breast CancerUnited States
-
Freenome Holdings Inc.RecruitingNewly-diagnosed Cancers | Non-cancer ControlsUnited States
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
Cancer Trials IrelandCompleted
-
University Hospital, GrenobleUniversity Grenoble Alps; Laboratoire TIMC-IMAGRecruitingBreast Cancer | Newly Diagnosed | Feasibility Study | Non-metastaticFrance
-
University of UtahCompletedNewly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast CancerUnited States
-
Ain Shams UniversityUnknownNewly Diagnosed Pediatric ITPEgypt
-
Central Hospital, Nancy, FranceUnknownNewly Diagnosed Breast Cancer | Surgery ProgrammedFrance
-
National Taiwan University HospitalUnknownPrimary Caregivers of Children Newly Diagnosed With CancerTaiwan